Introducing Cosm Medical: Invisalign for Women's Pelvic Health

`***Highly Confidential - do not share, discuss or forward without our written approval or you will be removed from this distribution and our Syndicate*** 

Welcome to The Healthcare Syndicate dealflow newsletter. You're receiving this invitation based on your expressed interest through our outreach or our other partner channels.

At The Healthcare Syndicate, our mission is simple: Get more investors to invest in healthcare, where innovation can directly change patient lives while offering incredible financial returns. We aim to be the change we want to see in the world by boldly backing high-potential early-stage healthcare companies before they attract big-name funds.

[Want early access to deals, priority allocation, and preferential economics? Secure your edge by upgrading to our premium offering today by signing up HERE]

Confidentiality Notice: Our community's strength lies in its privacy and trust. By accessing our deal flow, you agree to maintain strict confidentiality of all information shared, including company and founder details. This information is exclusively for your personal investment consideration and should not be forwarded or distributed under any circumstances. We're selectively expanding access to our network and appreciate your commitment to maintaining these confidentiality standards.

When Recovery from Pregnancy Doesn’t End After Birth:

[Thank you to my wife who gave the OK to share this — and I’m grateful, because this is something a lot of women go through silently]

Every time we tried to go for a jog together after our first child, the same thing happened.

A few minutes in, my wife would have to stop and run to the bathroom — not because of hydration, but because of unexpected urine leakage. We’d laugh it off, but I could tell it was frustrating.

What surprised me most was this happened despite her having a C-section. I had assumed pelvic floor issues were mostly tied to natural births. But the truth is, any pregnancy carried to term puts enormous stress on the female body — ligaments stretch, organs shift, and recovery can take months or years.

She’s not alone.
➡️ Up to 50% of women will experience a pelvic floor disorder in their lifetime
➡️ 1 in 5 will undergo surgery for prolapse or incontinence
➡️ The cost? Over $1.5B annually in the U.S. alone for pelvic organ prolapse surgeries — not including physical therapy, pads, diapers, or lost productivity
[Sources: Mayo Clinic, NIH, Obstetrics & Gynecology Journal]

And yet the standard of care — a century-old device called the pessary — is still fit by hand, using trial and error, in over 100 sizes.

That’s where Cosm comes in.

Why We’re Excited About Cosm Medical

Reinventing a legacy device with a 3D-printed, data-driven approach.: Pessaries are a 100-year-old solution for pelvic floor disorders (PFDs), and still rely on manual trial-and-error fitting. Cosm is replacing that guesswork with custom-fit 3D-printed devices Gynethotics™, or “Invisalign for the pelvic floor.” This isn’t just about comfort: better fit leads to higher compliance, improved outcomes, and fewer patients dropping out of care.

Creating a new $2B+ product category.: By starting with pelvic organ prolapse and stress urinary incontinence, then expanding into postpartum and post-surgical recovery, Cosm is building the world’s first comprehensive platform for personalized pelvic care. The market opportunity is global, underpenetrated, and underserved — exactly the kind of environment where category-defining companies are born.

Repeat founder leading experienced team: Founder Derek Sham is a repeat healthtech entrepreneur who’s assembled a strong bench across product, regulatory, and go-to-market. The company has launched its first device, built out a clinical education program, and is now layering on new high-ASP product lines that dramatically expand their addressable market.

Tier 1 investors: Cosm’s current convertible note includes renewed investments from both iGan Partners (Akira) and Fusion Fund (Lyft) — each of whom led previous rounds. With a $15M cap and strong momentum toward closing out the round, this is a rare opportunity to enter alongside top-tier partners.

If you’d like access to the pitch deck and deal memo, fill out this short form:

Disclaimer: This newsletter is for informational purposes only and does not constitute an offer to buy or sell any securities. Investment opportunities shared are only available to accredited investors, as defined by U.S. securities laws. Investing in startups is speculative and involves significant risks, including the potential loss of capital. Please conduct your own due diligence and consult with professional advisors before making any investment decisions.